<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20120910010806N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-25</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness Cognitive rehabilitation therapy (CRT) And Transcranial Direct Current Stimulation (TDCS) In people with spatial neglect</public_title>
      <acronym>CRT - TDCS</acronym>
      <scientific_title>Effectiveness Cognitive rehabilitation therapy (CRT) And Transcranial Direct Current Stimulation (TDCS) In people with spatial neglect</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>6</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/33976</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: one of the groups get both cognitive training exercises and trans cranial current stimulation. and the other group get cognitive training exercises and sham intervention, Randomization description: Review the records of in patients and outpatients stroke patients who referred to the department of the neurology of hospitals of Iran University of Medical Sciences between 1 to 12 months ago , allocated the  eligible patients into  2 groups by simple randomization using digits table by a blind person to the aim of the study, Blinding description: The participants will be unaware of the group they are entering.This means that after randomization by the therapist, the patient does not know which treatment method will be used for him Because only the remedy is mentioned in the satisfaction and there are no explanations for the two therapies.After completing the treatment, the data will be entered in SPSS and statistically analysis by blind person to the 2 treatment groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cerebral Vascular Accident.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: TDCS and Cognitive rehabilitation training. Group of intervention: first group of TDCS and cognitive rehabilitation. group 2: applying cognitive rehabilitation to the right hemisphere and the right hemisphere in this group, in addition to applying restoration computer tasks and saccadic training in addition to 10 sessions and each session for 20 min (at the same time with restoration training)with intensity of 2 ms, were applied while performing computer cognitive tasks. anode electrode was applied to the P4 area and catode electrode in area P. Intervention 2: Intervention group: cognitive rehabilitation training and sham. Group 2: using the cognitive rehabilitation of computer tasks associated with the اعمال of the right hemisphere and the left side of the left hemisphereThe intervention in this group, in addition to carrying out restoration computer assignments and saccadic training, were applied three times per week for 10 minutes and each session for 20 min (at the same time with restoration training), while applying computer cognitive tasks. anode electrode was applied to the P4 area and catode electrode in area P.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Parviz Ebadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 33, East of Zartosht, above Vali-e-Asr Square, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1413953461</zip>
        <telephone>+98 21 8880 2063</telephone>
        <email>p.ebadishokollahi@mail.sbu.ac.ir</email>
        <affiliation>Institute for Cognitive Science Studies</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Malahat Akbarfahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Rehabilitation Sciences, Iran University of Medical Sciences, Workers' Street, Shah Nazari Street, Mother's square, Mirdamad, Tehran</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15459-13478</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>rehab@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>stroke diagnoised by Neurologist and MRI
No aphasia and associated neurological disorders (Parkinson's, MS, ALS, Alzheimer's disease)
First stroke
25 - 80 years old
At least 9 successful grades education
Middle cerebral attract with spatial neglect symptom
1-12 months post stroke</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Not attending over 2 session cognitive treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Middle cerebral artery syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: TDCS and Cognitive rehabilitation training. Group of intervention: first group of TDCS and cognitive rehabilitation. group 2: applying cognitive rehabilitation to the right hemisphere and the right hemisphere in this group, in addition to applying restoration computer tasks and saccadic training in addition to 10 sessions and each session for 20 min (at the same time with restoration training)with intensity of 2 ms, were applied while performing computer cognitive tasks. anode electrode was applied to the P4 area and catode electrode in area P.</i_keyword>
      <i_keyword>Intervention group: cognitive rehabilitation training and sham. Group 2: using the cognitive rehabilitation of computer tasks associated with the اعمال of the right hemisphere and the left side of the left hemisphereThe intervention in this group, in addition to carrying out restoration computer assignments and saccadic training, were applied three times per week for 10 minutes and each session for 20 min (at the same time with restoration training), while applying computer cognitive tasks. anode electrode was applied to the P4 area and catode electrode in area P.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Improving function of visual attention. Timepoint: assessment in every 2 session. Method of measurement: star cancellation . line bisection . eye tracker device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-08-04</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
